Media
Webcast Abstracts
Title: Pharma 50 2026 Forecast: Sneak Peek
Date: April 2026
Abstract:
The “Pharma 50 Forecast 2026” will be a virtual event that will unveil a proprietary “Innovation Index” ranking the top 50 pharmaceutical companies. Powering this index is a predictive model that synthesizes two core data pillars: first, we will expand financial data to include R&D and SG&A expenses to measure each company’s “Financial Velocity”; second, we will integrate existing clinical trial data to create a “Pipeline Momentum” score. By combining these historical financials and forward-looking indicators, we will share an exclusive 2026 forecast for revenue and R&D spend. We will also provide a scoop of the top 25 pharma companies are leading in terms of revenue and R&D intensity.
Title: Global R&D Funding Forecast: A Look at What 2027 Holds
Date: October 2026
Abstract:
We will share a forecast for the global R&D spending trends of the coming year by building on a foundational econometric engine that synthesizes historical data from sources such as the World Bank and International Monetary Fund. We will share a baseline projection for national R&D intensity and expenditure, then adjust these figures for the cumulative impact of inflation to reveal the true purchasing power of R&D investments. Our analysis will also include an analysis of the latest trends related to R&D investments from the U.S. and China.